Editor’s note: The first part of this series appeared in the Aug. 5-11, 2009, issue, and the second part appeared in the Oct. 14-20, 2009, issue.
By Susan Johnson
The U.S. government has plans to deal with an expected swine flu (H1N1) pandemic predicted for this fall. Since the World Health Organization(WHO) has declared a
Level 6” status for this health threat, several pieces of legislation are prepared to give the federal government new powers superseding those of states and localities to protect their citizens. But not everyone agrees this level of government control is justified and may, in fact, be unconstitutional.
Questions for the CDC
On a General Questions and Answers on 2009 H1N1 Influenza Vaccine Safety
sheet, the Centers for Disease Control & Prevention (CDC) said:
We expect the 2009 H1N1 influenza vaccine to have a similar safety profile as seasonal flu vaccines, which have a very good safety track record. Over the years, hundreds of millions of Americans have received seasonal flu vaccines. The most common side effects following flu vaccinations are mild, such as soreness, redness, tenderness or swelling where the shot was given. The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) will be closely monitoring for any signs that the vaccine is causing unexpected adverse reactions, and we will work with state and local health officials to investigate any unusual events.
As for side effects, the CDC said:
CDC expects that any side effects following vaccination with the 2009 H1N1 vaccine would be rare. If side effects occur, they will likely be similar to those experienced following seasonal influenza vaccine. Mild problems that may be experienced include soreness, redness, or swelling where the shot was given, fainting (mainly adolescents), headache, muscle aches, fever and nausea. If these problems occur, they usually begin soon after the shot and last 1-2 days. Life-threatening allergic reactions to vaccines are very rare. If they do occur, it is usually within a few minutes to a few hours after the shot is given.
Addressing the question of monitoring for safety:
CDC and its partners will use multiple systems to monitor the safety of 2009 H1N1 influenza vaccine. Two of the primary systems that will be used to monitor the safety of these vaccines after they are in widespread use are: the Vaccine Adverse Reporting System (VAERS), which is jointly operated with FDA, and the Vaccine Safety Datalink (VSD) Project.
In a Global Alert and Response (GAR) fact sheet, the WHO said:
Licensed vaccines, including influenza vaccines, are held to a very high standard of safety. Likewise, all possible precautions will be taken to ensure safety of new pandemic vaccines and results from clinical trials, currently ongoing or soon to be initiated, will be taken into consideration by the regulatory authorities in their decision to license pandemic vaccines. In early June, WHO held a consultation of experts which reviewed the safety of adjuvants, or substances added to vaccines to make them more effective; no significant safety concerns were identified. Vaccine safety will be carefully monitored through post-marketing surveillance.
In reference to one severe adverse reaction that occurred in the 1976 swine flu vaccination campaign, WHO said:
Guillain-Barré Syndrome (GBS) is an acute disorder of the nervous system. It sometimes develops following a variety of infections, including influenza. Studies suggest that seasonal influenza vaccines could sometimes be associated with an increased risk of Guillain-Barré Syndrome on the order of one to two cases per million vaccinated persons. During the 1976 influenza vaccination campaign, about 10 persons per million vaccinated persons developed GBS, which stopped the vaccination campaign and led to the withdrawal of the vaccine.
Deborah Dupré, mentioned earlier, writes in a report in Examiner.com,
Part 1: The H1N1 swine flu experimental vaccination, martial law and eugenics story,
World leading economist, Prof. Michel Chossudovsky maintains that the H1N1 epidemiological data is ‘fabricated, falsified and manipulated’ and a political ploy ‘to create a crisis where there is no crisis.’
According to Chossodovsky, the WHO Level six pandemic is diverting public attention from a social crisis ‘largely the consequence of a deep-seated global economic depression’ and ushers Martial Law into the U.S., according to Chossudovsky. (Chossudovsky, Martial Law and the Militarization of Public Health: The Worldwide H12N1 Flu Vaccination Program, July 26,0 2009).
The flu pandemic is used to foreclose organized resistance against the government’s economic policies in support of the financial elites. It provides both a pretext and a justification to adopt emergency procedures. Under the existing legislation in the U.S. Martial Law, implying the suspension of constitutional government, could be invoked in the case of ‘A Catastrophic Emergency’ including the H1N1 swine flu pandemic.
(Chossudovsky, July 26, 2009).
Two points that independent researchers agree related to H1N1 are: the ‘pandemic’ will be highly profitable for corporations, and the Pentagon is positioning for military control of the U.S. health system.
Michel Chossudovsky is a Canadian economist and professor of economics at the University of Ottawa. He has taught as visiting professor at academic institutions in Western Europe, Latin America and Southeast Asia, has acted as economic adviser to governments of developing countries and has worked as a consultant for several international organizations. He is editor for the Centre for Research on Globalization, which operates a Web site at globalresearch.ca.
Mike Stobbe, AP medical writer, stated in a July 17, 2009, post:
Vaccine makers and federal officials will be immune from lawsuits that result from any new swine flu vaccine, under a document signed by Secretary of Health and Human Services Kathleen Sibelius, government health officials said Friday.
Since the 1980s, the government has protected vaccine makers against lawsuits over the use of childhood vaccines. Instead, a federal court handles claims and decides who will be paid from a special fund.
The document signed by Sibelius [in June] grants immunity to those making a swine flu vaccine, under the provisions of a 2006 law for public health emergencies. It allows for a compensation fund, if needed.
The government takes such steps to encourage drug companies to make vaccines, and it’s worked. Federal officials have contracted with the manufacturers to make a swine flu vaccine. First identified in April, swine flu has so far caused about 263 deaths, according to numbers released by the Centers for Disease Control and Prevention on Friday.
Adjuvants in the vaccines?
Although vaccines can be dangerous in themselves, Health Freedom Alliance warns:
A further source of toxicity in the case of the flu vaccines are the adjuvants, substances added in order to boost the immunogenicity of the vaccines. There is a large literature on the toxicities of adjuvants. Most flu vaccines contain dangerous levels of mercury in the form of thimerosal, a deadly preservative 50 times more toxic than mercury itself.
This was stated by Dr. Joseph Mercola, an osteopathic physician, health activist and entrepreneur practicing in Hoffman Estates, Ill. A graduate of the University of Illinois and Midwestern University, he is the author of two New York Times bestsellers, The No-Grain Diet (with Alison Rose Levy) and The Great Bird Flu Hoax, together with several other books. Mercola is best known as founder and editor of the alternative-medicine Web site Mercola.com, where he advocates dietary and lifestyle approaches to health and markets a variety of health-related products. He is critical of many of the practices of mainstream medicine and the Food and Drug Administration (FDA), particularly vaccination and the use of prescription drugs and surgery. He has received two warnings from the FDA for marketing nutritional products in a manner that violated the Federal Food, Drug and Cosmetic Act.
Some questions have been raised about the possibility of adjuvants in the H1N1 vaccine. The
General Questions and Answers on 2009 H1N1 Influenza Vaccine Safety
According to current federal plans, only unadjuvanted vaccines will be used in the United States during the flu season. This includes all of the 2009 H1N1 and seasonal influenza vaccines that will be available for children and adults in both the injectable and nasal spray formulations. None of these influenza vaccines will contain adjuvants.
However, a report from MSNBC.com, dated July 23, 2009, said:
The U.S. government has bought 195 million doses of H1N1 swine flu vaccine for a possible autumn vaccination campaign. … The U.S. Health and Human Services has also contracted for 120 million doses of adjuvant, a compound to stretch the number of doses of vaccine needed, the deparatment’s Dr. Robin Robinson told a meeting of Food and Drug Administration advisers.
The Rock River Times contacted the CDC for clarification. Thomas W. Skinner, media contact person, told us,
We have purchased enough antigen to produce up to 251 million doses of vaccine if we need them. We are probably not going to be needing adjuvants.
To be continued…
From the October 21-27, 2009 issue